FOR RELEASE 2/10/2014, Monday
FOR RELEASE MONDAY, FEBRUARY 10, 2014
BRIDGEWATER, NJ — Bausch + Lomb, a leading global eye health company, has begun the initial roll-out of its breakthrough monthly Bausch + Lomb ULTRA™ contact lens with MoistureSeal™ technology. The new lens technology, which has been studied and developed for seven years, combines a breakthrough material with new manufacturing processes to produce a contact lens that breaks the cycle of discomfort for unsurpassed comfort and vision all day.1
Bausch + Lomb ULTRA contact lenses were formally introduced during the company’s educational initiative for eye care professionals (ECPs). The all-day training program enabled more than 300 eye care professionals to gain first-hand experience and understanding of the science, technology and patient benefits associated with the new material.
“The level of excitement for this new technology among eye care professionals underscores the increasing need for a lens that breaks the cycle of discomfort and better addresses the demands of today’s contact lens user,” said Joseph Barr, OD, MS, FAAO, vice president, Medical Affairs, Pharmaceuticals & Vision Care, Bausch + Lomb. “With patients spending more than 10 hours each day using digital devices, we know that it is critical to surpass current standards for comfort, vision, and eye health. We believe that Bausch + Lomb ULTRA does just that.”
"As I strive to provide my patients solutions that will satisfy their vision demands in this new era of vision care, I am impressed with the superior vision and end of day comfort offered by Bausch + Lomb ULTRA contact lenses, which has truly been a long time coming," said Keith Basinger, OD. “The breakthrough MoistureSeal technology appears to offer an unmatched contact lens wearing experience and I am excited to be one of the first to offer the new lenses to my patients."
Bausch + Lomb received FDA marketing clearance for the frequent replacement and monthly modality silicone hydrogel contact lenses in September 2013. This latest development builds on Bausch + Lomb’s track record of breakthrough innovations, including Biotrue® ONEday contact lenses, Biotrue multi-purpose solution and PureVision®2 multi-focal for presbyopia contact lenses.
The Bausch + Lomb ULTRA contact lenses are now being distributed in select markets with a national roll-out scheduled for spring 2014.
About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments. We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.
1 Results from a 22-investigator, multi-site study of Bausch + Lomb contact lenses with MoistureSeal™ technology, with a total of 380 eligible subjects. After 7 days of wear, subjects completed an online survey. Subjects rated Bausch + Lomb contact lens performance across a range of attributes and compared the performance to their habitual lenses.
®/™are trademarks of Bausch & Lomb Incorporated or its affiliates.
News Media Contacts:
Public Relations Product Manager, Bausch + Lomb
(585) 338-8095 or email@example.com
Zeno Group, on behalf of Bausch + Lomb
(212) 299-8970 or firstname.lastname@example.org